Floatz logo

Quadrivalent Inactivated Influenza Vaccine

Clinical Stage I Cutaneous Melanoma AJCC v8

Carlo ContrerasvaccinePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

151 Active assets in the Clinical Stage I Cutaneous Melanoma AJCC v8 cohort.

Asset / SponsorPhaseRating
Alpha-Interferon
MIPO Clinic
Phase 3BBB
DACARBAZINE
Linnaeus Therapeutics, Inc.
Phase 3BBB
TIL
City of Hope Medical Center
Phase 2BBB
CIS-DIAMMINEDICHLOROPLATINUM II
MIPO Clinic
Phase 3BBB
Tyrosinase Peptide
University of Southern California
Phase 3BBB

View all 50 →

Same molecule, other indications

Quadrivalent Inactivated Influenza Vaccine is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
69 / 100
View asset →
viral infectious diseaseDormant
BB
Indicative ·
65 / 100
View asset →
lung cancerDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →